Vincerx Pharma, Inc.
VINC
$0.8145
$0.00550.68%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 41.83% | 48.11% | 38.02% | 36.24% | 20.15% |
| Total Depreciation and Amortization | 18.82% | 18.86% | 18.77% | -2.56% | -13.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 140.47% | -32.85% | 72.92% | -13.90% | 268.99% |
| Change in Net Operating Assets | -157.59% | 23.66% | -232.88% | -310.88% | -388.54% |
| Cash from Operations | 39.54% | 48.18% | 39.13% | 32.13% | 19.24% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -107.89% | 162.72% | 202.66% | 202.27% | 176.09% |
| Cash from Investing | -107.89% | 162.72% | 202.66% | 202.27% | 176.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12,605.22% | 12,605.22% | -59.01% | -59.29% | -74.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12,605.22% | 12,605.22% | -59.01% | -59.29% | -74.48% |
| Foreign Exchange rate Adjustments | 6.67% | -119.35% | -97.62% | -156.34% | 30.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 60.54% | 101.69% | 100.69% | 101.12% | 60.07% |
